首页 > 最新文献

Pneumologie最新文献

英文 中文
[Pulmonary involvement in idiopathic inflammatory myopathies]. [特发性炎症性肌病的肺部受累]。
IF 1.2 Q3 Medicine Pub Date : 2024-03-01 Epub Date: 2023-08-30 DOI: 10.1055/a-2129-3575
Melanie Berger, Maximilian Zimmermann, Michael Kreuter, Johannes Strunk, Wolfram Windisch, Jakob Höppner, Ilka Plath, Falk Schumacher

Idiopathic inflammatory myopathies are rare systemic diseases with different types of pulmonary manifestations depending on the underlying aetiology; here, interstitial lung diseases (ILD) are the most frequently found patterns depending on the underlying disorder. There is a lack of sufficient prospective studies on this heterogeneous group of patients, particularly in case of ILD being involved. The diagnosis is based upon guideline recommendations for ILD and requires a multidisciplinary discussion within a team with specific expertise in this field. Myositis specific antibodies and myositis associated antibodies form an essential part of the diagnostic tools and may also be associated with a certain phenotype or disease progression. Anti-t-RNA-synthetase antibodies (Anti-ARS) and anti-melanoma differentiation-associated gene 5 antibodies (MDA5) play an important clinical role for treatment the estimation of response and prognosis. The most common ILD patterns are nonspecific interstitial pneumonia (NSIP) and organising pneumonia (OP) or a mixed pattern of both. Treatment is based on systemic steroids and early initiation of other immunosuppressant drugs. Evidence for this is, however, sparse, since most of the studies having investigated treatment modalities are of retrospective nature, even though some new prospective data may be useful for the establishment of treatment pathways in the future.

特发性炎症性肌病是一种罕见的全身性疾病,根据潜在的病因会有不同类型的肺部表现。对这一异质性患者群体缺乏足够的前瞻性研究,尤其是在涉及 ILD 的情况下。诊断以 ILD 指南的建议为基础,需要由具有该领域专业知识的团队进行多学科讨论。肌炎特异性抗体和肌炎相关抗体是诊断工具的重要组成部分,也可能与某种表型或疾病进展有关。抗t-RNA合成酶抗体(Anti-RARS)和抗黑色素瘤分化相关基因5抗体(MDA5)在治疗、反应评估和预后方面发挥着重要的临床作用。最常见的 ILD 模式是非特异性间质性肺炎(NSIP)和机化性肺炎(OP)或两者的混合模式。治疗的基础是全身使用类固醇和尽早开始使用其他免疫抑制剂。不过,这方面的证据并不多,因为大多数对治疗方式进行调查的研究都是回顾性的,尽管一些新的前瞻性数据可能对未来治疗路径的确立有所帮助。
{"title":"[Pulmonary involvement in idiopathic inflammatory myopathies].","authors":"Melanie Berger, Maximilian Zimmermann, Michael Kreuter, Johannes Strunk, Wolfram Windisch, Jakob Höppner, Ilka Plath, Falk Schumacher","doi":"10.1055/a-2129-3575","DOIUrl":"10.1055/a-2129-3575","url":null,"abstract":"<p><p>Idiopathic inflammatory myopathies are rare systemic diseases with different types of pulmonary manifestations depending on the underlying aetiology; here, interstitial lung diseases (ILD) are the most frequently found patterns depending on the underlying disorder. There is a lack of sufficient prospective studies on this heterogeneous group of patients, particularly in case of ILD being involved. The diagnosis is based upon guideline recommendations for ILD and requires a multidisciplinary discussion within a team with specific expertise in this field. Myositis specific antibodies and myositis associated antibodies form an essential part of the diagnostic tools and may also be associated with a certain phenotype or disease progression. Anti-t-RNA-synthetase antibodies (Anti-ARS) and anti-melanoma differentiation-associated gene 5 antibodies (MDA5) play an important clinical role for treatment the estimation of response and prognosis. The most common ILD patterns are nonspecific interstitial pneumonia (NSIP) and organising pneumonia (OP) or a mixed pattern of both. Treatment is based on systemic steroids and early initiation of other immunosuppressant drugs. Evidence for this is, however, sparse, since most of the studies having investigated treatment modalities are of retrospective nature, even though some new prospective data may be useful for the establishment of treatment pathways in the future.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10112072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interprofessional weaning boards and weaning consults for long-term ventilated patients: A qualitative study of perceived potential for patient care]. [长期通气患者的跨专业断奶委员会和断奶咨询:对患者护理感知潜力的定性研究]。
IF 1.2 Q3 Medicine Pub Date : 2024-03-01 Epub Date: 2023-10-19 DOI: 10.1055/a-2161-6014
Sabrina Keller, Johanna Forstner, Aline Weis, Elena Biehler, Franziska Trudzinski, Julia Michels, Benjamin Neetz, Felix Herth, Armin Schneider, Alessandro Ghiani, Joachim Szecsenyi, Michel Wensing, Regina Poß-Doering

Background: The PRiVENT project aims to improve the care of invasively ventilated patients and to reduce the number of out-of-hospital long-term ventilated patients. PRiVENT offers intensive care units the opportunity to exchange information with experts from specialized weaning centers in interprofessional weaning boards and weaning consults and to exploit the full weaning potential of the patients. In the context of the accompanying process evaluation, the PRiVENT intervention components will be examined for sustainability, scalability and effectiveness, and the interprofessional collaboration between intensive care units and the responsible weaning centers will be investigated in order to identify potentials for the care of invasively managed patients.

Methods: In a qualitative cross-sectional study, semistructured, problem-oriented interviews were conducted with care providers of participating ICUs. The data were digitally recorded, pseudonymized and verbatim transcribed. Data analysis was based on Brown and Clarke's Thematic Analysis and the Consolidated Framework for Implementation Research. MAXQDA 2020 software was used to organize the data.

Results: Fourteen interviews were conducted with ICU care providers. The early transfer of patients to a weaning center and the integration of pulmonary expertise into routine care were identified as positively perceived potentials of the weaning boards and weaning consults. Especially in critically ill, multimorbid patients suffering from COVID-19, the expertise of the weaning centers was considered helpful. Due to heavy workloads, nurses were unable to participate in weaning boards and weaning consults.

Conclusion: Interprofessional collaboration between weaning centers and ICUs in weaning boards and weaning consults can improve the care of invasively ventilated patients. Strategies to promote the involvement of nurses should be discussed and developed.

背景:PRiVENT项目旨在改善对有创通气患者的护理,减少院外长期通气患者的数量。PRiVENT为重症监护室提供了与专业断奶中心的专家在跨专业断奶委员会和断奶咨询中交换信息的机会,并充分利用患者的断奶潜力。在伴随过程评估的背景下,将检查PRiVENT干预组件的可持续性、可扩展性和有效性,并将调查重症监护室和负责断奶中心之间的跨专业合作,以确定护理侵入性管理患者的潜力。方法:在一项定性的横断面研究中,对参与ICU的护理提供者进行了半结构的、以问题为导向的访谈。这些数据经过数字记录、化名和逐字转录。数据分析基于Brown和Clarke的专题分析和实施研究综合框架。MAXQDA 2020软件用于组织数据。结果:对ICU护理人员进行了14次访谈。早期将患者转移到断奶中心以及将肺部专业知识纳入常规护理被认为是断奶委员会和断奶咨询的积极潜力。特别是在患有新冠肺炎的危重、多发病患者中,断奶中心的专业知识被认为是有帮助的。由于工作量大,护士无法参加断奶委员会和断奶咨询。结论:断奶中心和ICU在断奶委员会和断奶咨询方面的跨专业合作可以改善对有创通气患者的护理。应讨论和制定促进护士参与的策略。
{"title":"[Interprofessional weaning boards and weaning consults for long-term ventilated patients: A qualitative study of perceived potential for patient care].","authors":"Sabrina Keller, Johanna Forstner, Aline Weis, Elena Biehler, Franziska Trudzinski, Julia Michels, Benjamin Neetz, Felix Herth, Armin Schneider, Alessandro Ghiani, Joachim Szecsenyi, Michel Wensing, Regina Poß-Doering","doi":"10.1055/a-2161-6014","DOIUrl":"10.1055/a-2161-6014","url":null,"abstract":"<p><strong>Background: </strong>The PRiVENT project aims to improve the care of invasively ventilated patients and to reduce the number of out-of-hospital long-term ventilated patients. PRiVENT offers intensive care units the opportunity to exchange information with experts from specialized weaning centers in interprofessional weaning boards and weaning consults and to exploit the full weaning potential of the patients. In the context of the accompanying process evaluation, the PRiVENT intervention components will be examined for sustainability, scalability and effectiveness, and the interprofessional collaboration between intensive care units and the responsible weaning centers will be investigated in order to identify potentials for the care of invasively managed patients.</p><p><strong>Methods: </strong>In a qualitative cross-sectional study, semistructured, problem-oriented interviews were conducted with care providers of participating ICUs. The data were digitally recorded, pseudonymized and verbatim transcribed. Data analysis was based on Brown and Clarke's Thematic Analysis and the Consolidated Framework for Implementation Research. MAXQDA 2020 software was used to organize the data.</p><p><strong>Results: </strong>Fourteen interviews were conducted with ICU care providers. The early transfer of patients to a weaning center and the integration of pulmonary expertise into routine care were identified as positively perceived potentials of the weaning boards and weaning consults. Especially in critically ill, multimorbid patients suffering from COVID-19, the expertise of the weaning centers was considered helpful. Due to heavy workloads, nurses were unable to participate in weaning boards and weaning consults.</p><p><strong>Conclusion: </strong>Interprofessional collaboration between weaning centers and ICUs in weaning boards and weaning consults can improve the care of invasively ventilated patients. Strategies to promote the involvement of nurses should be discussed and developed.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Carcinoma, tuberculosis, atypical pneumonia - or may be pulmonary tularemia? Two case reports]. [癌症、肺结核、非典型肺炎——或者可能是肺兔热病?两例报告]。
IF 1.2 Q3 Medicine Pub Date : 2024-03-01 Epub Date: 2023-10-19 DOI: 10.1055/a-2161-5792
Martin Kimmich, Maja Jakob

Tularemia is a rare zoonotic disease, endemic in rural areas all over Germany. It's clinical manifestation following inhalation of infectious aerosols may resemble pulmonary neoplasia, other atypical pneumonias or tuberculosis. Here we describe two representative cases with pulmonary tularemia.

图拉雷米亚是一种罕见的人畜共患疾病,流行于德国各地的农村地区。吸入传染性气溶胶后的临床表现可能类似于肺肿瘤、其他非典型肺炎或肺结核。在这里,我们描述两个具有代表性的肺瓦雷病病例。
{"title":"[Carcinoma, tuberculosis, atypical pneumonia - or may be pulmonary tularemia? Two case reports].","authors":"Martin Kimmich, Maja Jakob","doi":"10.1055/a-2161-5792","DOIUrl":"10.1055/a-2161-5792","url":null,"abstract":"<p><p>Tularemia is a rare zoonotic disease, endemic in rural areas all over Germany. It's clinical manifestation following inhalation of infectious aerosols may resemble pulmonary neoplasia, other atypical pneumonias or tuberculosis. Here we describe two representative cases with pulmonary tularemia.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Therapeutic Pathways in Sarcoidosis. A Position Paper of the German Society of Respiratory Medicine (DGP)]. [肉样瘤病的治疗途径"。德国呼吸医学学会(DGP)的立场文件]。
IF 1.2 Q3 Medicine Pub Date : 2024-03-01 Epub Date: 2024-02-26 DOI: 10.1055/a-2259-1046
Dirk Skowasch, Francesco Bonella, Katharina Buschulte, Nikolaus Kneidinger, Peter Korsten, Michael Kreuter, Joachim Müller-Quernheim, Michael Pfeifer, Antje Prasse, Bernd Quadder, Oliver Sander, Jonas C Schupp, Helmut Sitter, Bernd Stachetzki, Christian Grohé

The present recommendations on the therapy of sarcoidosis of the German Respiratory Society (DGP) was written in 2023 as a German-language supplement and update of the international guidelines of the European Respiratory Society (ERS) from 2021. It contains 5 PICO questions (Patients, Intervention, Comparison, Outcomes) agreed in the consensus process, which are explained in the background text of the four articles: Confirmation of diagnosis and monitoring of the disease under therapy, general therapy recommendations, therapy of cutaneous sarcoidosis, therapy of cardiac sarcoidosis.

德国呼吸学会(DGP)肉样瘤病治疗建议于 2023 年编写,是对欧洲呼吸学会(ERS)2021 年国际指南的德语补充和更新。它包含在共识过程中达成一致的 5 个 PICO 问题(患者、干预、比较、结果),四篇文章的背景文字对此进行了解释:确诊和治疗中的疾病监测、一般治疗建议、皮肤肉样瘤病的治疗、心脏肉样瘤病的治疗。
{"title":"[Therapeutic Pathways in Sarcoidosis. A Position Paper of the German Society of Respiratory Medicine (DGP)].","authors":"Dirk Skowasch, Francesco Bonella, Katharina Buschulte, Nikolaus Kneidinger, Peter Korsten, Michael Kreuter, Joachim Müller-Quernheim, Michael Pfeifer, Antje Prasse, Bernd Quadder, Oliver Sander, Jonas C Schupp, Helmut Sitter, Bernd Stachetzki, Christian Grohé","doi":"10.1055/a-2259-1046","DOIUrl":"10.1055/a-2259-1046","url":null,"abstract":"<p><p>The present recommendations on the therapy of sarcoidosis of the German Respiratory Society (DGP) was written in 2023 as a German-language supplement and update of the international guidelines of the European Respiratory Society (ERS) from 2021. It contains 5 PICO questions (Patients, Intervention, Comparison, Outcomes) agreed in the consensus process, which are explained in the background text of the four articles: Confirmation of diagnosis and monitoring of the disease under therapy, general therapy recommendations, therapy of cutaneous sarcoidosis, therapy of cardiac sarcoidosis.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139973122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Task Force Dyspnoe unit (DU)]. [Dyspnoe 特遣部队 (DU)]。
IF 1.2 Q3 Medicine Pub Date : 2024-02-21 DOI: 10.1055/a-2238-4253
Dominic Dellweg, Georg Nilius, Achim Grünewaldt, Andreas Günther, Matthias Held, Martin Hetzel, Andreas Schlesinger, Robin Schlott, Georgios Sofianos, Markus Unnewehr, Thomas Voshaar, Winfried Randerath

Acute dyspnoea is one of the most common internal medicine symptoms in the emergency department. It arises from an acute illness or from the exacerbation of a chronic illness. Symptom-related emergency structures and corresponding structural guidelines already exist in the stroke and chest pain units for dealing with the leading symptoms of acute stroke and acute chest pain. These are lacking in Germany for the key symptom of dyspnoea, although the benefits of these structures have already been proven in other countries. The German Society for Pneumology and Respiratory Medicine (DGP) has now set up a task force together with the Association of Pneumology Clinics (VPK), in order to deal with the topic and develop appropriate structural guidelines for such "dyspnoea units" in Germany. At the end of the process, the certification of such units at German hospitals is optional.

急性呼吸困难是急诊科最常见的内科症状之一。它产生于急性疾病或慢性疾病的加重。在处理急性中风和急性胸痛的主要症状时,中风和胸痛科已经有了与症状相关的急诊结构和相应的结构指南。尽管这些机构的益处已在其他国家得到证实,但德国在呼吸困难这一主要症状方面还缺乏这些机构。目前,德国肺病与呼吸医学学会(DGP)与肺病诊所协会(VPK)共同成立了一个特别工作组,负责处理这一问题,并为德国的此类 "呼吸困难单元 "制定适当的结构指南。在这一过程结束后,德国医院可选择对此类科室进行认证。
{"title":"[Task Force Dyspnoe unit (DU)].","authors":"Dominic Dellweg, Georg Nilius, Achim Grünewaldt, Andreas Günther, Matthias Held, Martin Hetzel, Andreas Schlesinger, Robin Schlott, Georgios Sofianos, Markus Unnewehr, Thomas Voshaar, Winfried Randerath","doi":"10.1055/a-2238-4253","DOIUrl":"https://doi.org/10.1055/a-2238-4253","url":null,"abstract":"<p><p>Acute dyspnoea is one of the most common internal medicine symptoms in the emergency department. It arises from an acute illness or from the exacerbation of a chronic illness. Symptom-related emergency structures and corresponding structural guidelines already exist in the stroke and chest pain units for dealing with the leading symptoms of acute stroke and acute chest pain. These are lacking in Germany for the key symptom of dyspnoea, although the benefits of these structures have already been proven in other countries. The German Society for Pneumology and Respiratory Medicine (DGP) has now set up a task force together with the Association of Pneumology Clinics (VPK), in order to deal with the topic and develop appropriate structural guidelines for such \"dyspnoea units\" in Germany. At the end of the process, the certification of such units at German hospitals is optional.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139932489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of hospitalized patients with SARS-CoV-2 infection in two time periods of the pandemic]. [两个时期感染 SARS-CoV-2 的住院病人的比较]。
IF 1.2 Q3 Medicine Pub Date : 2024-02-20 DOI: 10.1055/a-2235-0214
Jan Eberhard Strehl, Santiago Ewig, Bernhard Schaaf

Objective: The aim of the investigation was to compare patients hospitalized with SARS-CoV-2 infection during 2020/2021 and 2022 with respect to the reason for hospitalization as well as severity of disease at admission, during follow-up and clinical outcomes.

Methods: The data of all patients patients hospitalized with SARS-CoV-2 infection during the periods of interest were collected. Severity of disease at admission and during follow-up was compared in all patients who were hospitalized because of SARS-CoV-2 infection.

Results: During the period of 2020 to 2021, overall n=1281 patients with SARS-CoV-2 infection were hospitalized as compared to n=580 in 2022. Of these, 90% and 42%, respectively, were admitted because of SARS-CoV-2 infection. The rates of nosocomial transmission increased from 5 to 18%. Severity of disease at admission and during follow-up was higher across all age groups in the first period. More patients were admitted to the ICU (25 versus 4%). Accordingly, hospital mortality was higher (17 versus 10%). Intubated patients had a high mortality of 74 and 80%, respectively, in both periods.

Conclusions: The severity at admission and during follow-up was much higher in the first period. In the second period, the burden of health care systems was only in part driven by disease severity but more by the need for isolation and nosocomial infections. Mortality of intubated patients was high.

调查目的调查旨在比较 2020/2021 年和 2022 年期间因感染 SARS-CoV-2 而住院的患者的住院原因、入院时的病情严重程度、随访期间和临床结果:方法:收集了相关时期内所有感染SARS-CoV-2住院患者的数据。比较了所有因感染 SARS-CoV-2 而住院的患者入院时和随访期间的病情严重程度:结果:在 2020 年至 2021 年期间,共有约 1281 名 SARS-CoV-2 感染者住院治疗,而 2022 年则有约 580 名。其中,分别有 90% 和 42% 的患者因感染 SARS-CoV-2 而入院。院内传播率从 5% 上升到 18%。在第一阶段,所有年龄组的患者在入院时和随访期间的病情严重程度都较高。更多患者住进了重症监护室(25% 对 4%)。因此,住院死亡率也更高(17% 对 10%)。在这两个时期,插管患者的死亡率分别为 74% 和 80%:结论:入院时和随访期间的严重程度在第一阶段要高得多。结论:入院时和随访期间的病情严重程度在第一阶段要高得多,而在第二阶段,医疗系统的负担部分是由病情严重程度造成的,但更多的是由隔离需求和院内感染造成的。插管病人的死亡率很高。
{"title":"[Comparison of hospitalized patients with SARS-CoV-2 infection in two time periods of the pandemic].","authors":"Jan Eberhard Strehl, Santiago Ewig, Bernhard Schaaf","doi":"10.1055/a-2235-0214","DOIUrl":"https://doi.org/10.1055/a-2235-0214","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the investigation was to compare patients hospitalized with SARS-CoV-2 infection during 2020/2021 and 2022 with respect to the reason for hospitalization as well as severity of disease at admission, during follow-up and clinical outcomes.</p><p><strong>Methods: </strong>The data of all patients patients hospitalized with SARS-CoV-2 infection during the periods of interest were collected. Severity of disease at admission and during follow-up was compared in all patients who were hospitalized because of SARS-CoV-2 infection.</p><p><strong>Results: </strong>During the period of 2020 to 2021, overall n=1281 patients with SARS-CoV-2 infection were hospitalized as compared to n=580 in 2022. Of these, 90% and 42%, respectively, were admitted because of SARS-CoV-2 infection. The rates of nosocomial transmission increased from 5 to 18%. Severity of disease at admission and during follow-up was higher across all age groups in the first period. More patients were admitted to the ICU (25 versus 4%). Accordingly, hospital mortality was higher (17 versus 10%). Intubated patients had a high mortality of 74 and 80%, respectively, in both periods.</p><p><strong>Conclusions: </strong>The severity at admission and during follow-up was much higher in the first period. In the second period, the burden of health care systems was only in part driven by disease severity but more by the need for isolation and nosocomial infections. Mortality of intubated patients was high.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139913264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From "processing" and "fermentation" to oxidative metabolism]. 【从“加工”和“发酵”到氧化代谢】。
IF 1.2 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-10-19 DOI: 10.1055/a-2183-7489
Ulrich Koehler, Mikail Aykut Degerli, Olaf Hildebrandt, Regina Conradt, Julian Koehler

The theory of the four humors or humorism (Hippocrates of Kos) viewed disease as an imbalance of the humors. Galen of Pergamon further developed the theory by describing digestion as a sequence of chemical reduction processes that convert into the various humours. Theophrastus von Hohenheim attempted to overcome humorism in the 16th century and establish medicine on a natural-philosophical-alchemical basis. The era of empirical-experimental chemically oriented medicine began with "iatrochemistry" in the 17th century. Franciscus Sylvius' concept of disease is based on an imbalance of acidic and alkaline fermentation. It was Lazarro Spallanzani who understood the digestive processes in the stomach as a chemical dissolution of food. The discovery of oxygen and the process of oxidation by Lavoisier laid the foundation for our understanding the physiology of metabolism.

四幽默理论或幽默主义(科斯的希波克拉底)认为疾病是幽默的失衡。佩加蒙的盖伦进一步发展了这一理论,他将消化描述为一系列转化为各种幽默的化学还原过程。Theoprastus von Hohenheim在16世纪试图克服幽默主义,并在自然哲学炼金术的基础上建立医学。实证实验化学导向医学的时代始于17世纪的“医学化学”。Franciscus Sylvius的疾病概念是基于酸性和碱性发酵的不平衡。正是Lazarro Spallanzani将胃中的消化过程理解为食物的化学溶解。拉瓦锡对氧的发现和氧化过程为我们理解代谢生理学奠定了基础。
{"title":"[From \"processing\" and \"fermentation\" to oxidative metabolism].","authors":"Ulrich Koehler, Mikail Aykut Degerli, Olaf Hildebrandt, Regina Conradt, Julian Koehler","doi":"10.1055/a-2183-7489","DOIUrl":"10.1055/a-2183-7489","url":null,"abstract":"<p><p>The theory of the four humors or humorism (Hippocrates of Kos) viewed disease as an imbalance of the humors. Galen of Pergamon further developed the theory by describing digestion as a sequence of chemical reduction processes that convert into the various humours. Theophrastus von Hohenheim attempted to overcome humorism in the 16th century and establish medicine on a natural-philosophical-alchemical basis. The era of empirical-experimental chemically oriented medicine began with \"iatrochemistry\" in the 17th century. Franciscus Sylvius' concept of disease is based on an imbalance of acidic and alkaline fermentation. It was Lazarro Spallanzani who understood the digestive processes in the stomach as a chemical dissolution of food. The discovery of oxygen and the process of oxidation by Lavoisier laid the foundation for our understanding the physiology of metabolism.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[4D electromagnetic navigation bronchoscopy for the diagnosis of peripheral pulmonary nodules - An overview and preliminary clinical results]. [4D电磁导航支气管镜用于诊断外周肺结节--概述和初步临床结果]。
IF 1.2 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-12-11 DOI: 10.1055/a-2193-0966
Thomas Bitter, Tielko Seeba, Jörn Schroeder-Richter, Michael Fröhlich, Wissam Duaer, Wael Abidi, Markus Peter Kindermann

Background: The diagnostic of peripheral pulmonary nodules (PPN) is a particular challenge in interventional bronchology, which is why navigation systems such as electromagnetic navigation (ENB) are increasingly being used. The 4D-ENB represents the most current development of the ENB. It utilizes inspiratory and expiratory CT scans for mapping and thus helps compensate for respiratory movements-induced CT-to-body divergence. The aim of this work was to present the first clinical data and experiences using the 4D-ENB method for diagnosis of PPNs.

Methods: We retrospectively describe the results of the first nine consecutive patient cases diagnosed at Klinikum Braunschweig using 4D-ENB in a unimodal diagnostic procedure.

Results: Of the first 9 PPNs examined by 4D-ENB, navigation and puncture of the lesion was successful in 8 patients (89%). Diagnostic biopsy was could be carried out in six out of nine patients (67%). There were no significant procedure-related complications.

Conclusion: Our preliminary data suggest that 4D-ENB is a promising new alternative for the diagnosis of PPNs. To further improve diagnostic yield, 4D-END, which lacks real-time visualization, should be embedded in a multimodal diagnostic procedure with rEBUS and/or fluoroscopy.

背景:外周肺结节(PPN)的诊断是介入性支气管病理学的一项特殊挑战,这也是电磁导航(ENB)等导航系统被越来越多地使用的原因。4D-ENB 代表了 ENB 的最新发展。它利用吸气和呼气CT扫描绘制地图,因此有助于补偿呼吸运动引起的CT与身体的偏差。这项工作的目的是首次展示使用 4D-ENB 方法诊断 PPNs 的临床数据和经验:我们回顾性地描述了布伦瑞克医学院在单模态诊断程序中使用 4D-ENB 诊断的首批 9 个连续病例的结果:结果:在使用 4D-ENB 检查的前 9 例 PPN 中,8 例患者(89%)成功进行了导航和病灶穿刺。九名患者中有六名(67%)可以进行诊断性活检。没有出现与手术相关的重大并发症:我们的初步数据表明,4D-ENB 是诊断 PPNs 的一种很有前途的新选择。为了进一步提高诊断率,缺乏实时可视化的4D-END应与rEBUS和/或透视一起嵌入多模态诊断程序中。
{"title":"[4D electromagnetic navigation bronchoscopy for the diagnosis of peripheral pulmonary nodules - An overview and preliminary clinical results].","authors":"Thomas Bitter, Tielko Seeba, Jörn Schroeder-Richter, Michael Fröhlich, Wissam Duaer, Wael Abidi, Markus Peter Kindermann","doi":"10.1055/a-2193-0966","DOIUrl":"10.1055/a-2193-0966","url":null,"abstract":"<p><strong>Background: </strong>The diagnostic of peripheral pulmonary nodules (PPN) is a particular challenge in interventional bronchology, which is why navigation systems such as electromagnetic navigation (ENB) are increasingly being used. The 4D-ENB represents the most current development of the ENB. It utilizes inspiratory and expiratory CT scans for mapping and thus helps compensate for respiratory movements-induced CT-to-body divergence. The aim of this work was to present the first clinical data and experiences using the 4D-ENB method for diagnosis of PPNs.</p><p><strong>Methods: </strong>We retrospectively describe the results of the first nine consecutive patient cases diagnosed at Klinikum Braunschweig using 4D-ENB in a unimodal diagnostic procedure.</p><p><strong>Results: </strong>Of the first 9 PPNs examined by 4D-ENB, navigation and puncture of the lesion was successful in 8 patients (89%). Diagnostic biopsy was could be carried out in six out of nine patients (67%). There were no significant procedure-related complications.</p><p><strong>Conclusion: </strong>Our preliminary data suggest that 4D-ENB is a promising new alternative for the diagnosis of PPNs. To further improve diagnostic yield, 4D-END, which lacks real-time visualization, should be embedded in a multimodal diagnostic procedure with rEBUS and/or fluoroscopy.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Dual Membership: German Respiratory Society and European Respiratory Society (ERS)]. [双重会员资格:德国呼吸学会和欧洲呼吸学会 (ERS)]。
IF 1.2 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-01-29 DOI: 10.1055/a-2215-3236
Anja Flender, Wolfram Windisch, Monika Gappa
{"title":"[Dual Membership: German Respiratory Society and European Respiratory Society (ERS)].","authors":"Anja Flender, Wolfram Windisch, Monika Gappa","doi":"10.1055/a-2215-3236","DOIUrl":"10.1055/a-2215-3236","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Technical aspects and innovations in non-invasive and invasive ventilation]. [无创和有创通气的技术方面和创新]。
IF 1.2 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2024-02-16 DOI: 10.1055/a-2229-3854
Dominic Dellweg, Philipp M Lepper

Non-invasive and invasive ventilation have become essential for therapy in acute and chronic respiratory failure. More than one-third of patients in intensive care units receive invasive ventilation, and the number of ventilated patients in out-of-hospital care is also steadily increasing. While normalization of blood gases was considered the most significant goal in past decades, and the idea that mechanical ventilation also poses dangers played little role, the dominant thought at present is the application of ventilation from the most protective point of view possible. Because fundamental change in equipment technology is likely to be difficult, improvement of protective ventilation and further development of understanding of pathophysiologic processes in acute and chronic respiratory failure will continue to be of great importance in the future. This article summarizes different aspects of the technical basis of noninvasive and invasive ventilation and their practical implementation.

无创和有创通气已成为治疗急性和慢性呼吸衰竭的基本方法。在重症监护室中,超过三分之一的患者接受有创通气治疗,院外治疗中接受通气治疗的患者人数也在稳步增加。在过去的几十年中,血气正常化被认为是最重要的目标,而机械通气也会带来危险的观点则几乎没有起到任何作用。由于设备技术很难发生根本性改变,因此改进保护性通气以及进一步了解急性和慢性呼吸衰竭的病理生理过程在未来仍将具有重要意义。本文总结了无创通气和有创通气的技术基础及其实际应用的各个方面。
{"title":"[Technical aspects and innovations in non-invasive and invasive ventilation].","authors":"Dominic Dellweg, Philipp M Lepper","doi":"10.1055/a-2229-3854","DOIUrl":"10.1055/a-2229-3854","url":null,"abstract":"<p><p>Non-invasive and invasive ventilation have become essential for therapy in acute and chronic respiratory failure. More than one-third of patients in intensive care units receive invasive ventilation, and the number of ventilated patients in out-of-hospital care is also steadily increasing. While normalization of blood gases was considered the most significant goal in past decades, and the idea that mechanical ventilation also poses dangers played little role, the dominant thought at present is the application of ventilation from the most protective point of view possible. Because fundamental change in equipment technology is likely to be difficult, improvement of protective ventilation and further development of understanding of pathophysiologic processes in acute and chronic respiratory failure will continue to be of great importance in the future. This article summarizes different aspects of the technical basis of noninvasive and invasive ventilation and their practical implementation.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139747267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pneumologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1